We have three topics for you today: We talk about our recent paper on the use of second-line immunotherapy in kidney cancer, the controversy over whether a cancer clinical trial was unethical, and the results of the randomized clinical trial CASSIOPEIA.
Kidney Cancer: doi.org/10.1001/jamanetworkopen.2021.24728
CASSIOPEIA doi.org/10.1016/S1470-2045(21)00428-9
Back us on Patreon! www.patreon.com/plenarysession
Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew